Oventus wins new customers in the United States
Queensland medical device manfacturer Oventus (ASX:: OVN) has won two new customers in the United States for its O2Vent sleep apnea treatment device. The company announced Delaware Sleep Disorder Centres and Reliable Respiratory would adopt the company’s O2Vent device as an apnea treatment across 10 US health centres. A minimum of twenty devices will be…